Considering taking medication to treat type 2 diabetes mellitus?
Below is a list of common medications used to treat or reduce the symptoms of type 2 diabetes mellitus. Follow the links to read common uses, side effects, dosage details and read user reviews for the drugs listed below.
326 medications found for ‘type 2 diabetes mellitus’
Drug Name
Label
Type
User Reviews
Reviews
actoplus met xr 15 mg-1,000 mg tablet,extended release hypoglycemics, insulin-response enhancer-thiazolidinedionesOn LabelRXReviews
basaglar tempo pen (u-100) insulin 100 unit/ml (3 ml) subcutaneous intermediate-, long-acting, and combination insulinsOn LabelRXReviews
bydureon 2 mg/0.65 ml subcutaneous pen injector antihyperglycemic, incretin mimetic agentOn LabelRXReviews
bydureon bcise 2 mg/0.85 ml subcutaneous auto-injector antihyperglycemic, incretin mimetic agentOn LabelRXReviews
canagliflozin-metformin tablet, immediate release and extended release, biphasic 24hr (tablet,immed & ext release,biphasic 24hr)On LabelRXReviews
dapagliflozin-metformin tablet, immediate release and extended release, biphasic 24hr (tablet,immed & ext release,biphasic 24hr)On LabelRXReviews
empagliflozin-metformin tablet, immediate release and extended release, biphasic 24hr (tablet,immed & ext release,biphasic 24hr)On LabelRXReviews
fiasp penfill u-100 insulin 100 unit/ml (3 ml) subcutaneous cartridge short-acting insulinsOn LabelRXReviews
insulin aspar prt-insulin aspart 100 unit/ml (70-30) subcutaneous soln intermediate-, long-acting, and combination insulinsOn LabelRXReviews
insulin degludec (u-200) 200 unit/ml (3 ml) subcutaneous pen intermediate-, long-acting, and combination insulinsOn LabelRXReviews
insulin glargine (u-100) 100 unit/ml subcutaneous solution intermediate-, long-acting, and combination insulinsOn LabelRXReviews
insulin glargine-yfgn (u-100) 100 unit/ml (3 ml) subcutaneous pen intermediate-, long-acting, and combination insulinsOn LabelRXReviews
insulin lispro protamine-lispro 100 unit/ml (75-25) subcutaneous pen intermediate-, long-acting, and combination insulinsOn LabelRXReviews
levemir flexpen 100 unit/ml (3 ml) solution subcutaneous insulin pen intermediate-, long-acting, and combination insulinsOn LabelRXReviews
linagliptin-metformin tablet, immediate release and extended release, biphasic 24hr (tablet,immed & ext release,biphasic 24hr)On LabelRXReviews
lyumjev kwikpen u-200 insulin 200 unit/ml (3 ml) subcutaneous short-acting insulinsOn LabelRXReviews
mounjaro 2.5 mg/0.5 ml subcutaneous pen injector antihyperglycemic, incretin mimetic agentOn LabelRXReviews
novolin n flexpen 100 unit/ml (3 ml) subcutaneous insulin pen intermediate-, long-acting, and combination insulinsOn LabelOTCReviews
novolin r flexpen 100 unit/ml (3 ml) subcutaneous insulin pen short-acting insulinsOn LabelOTCReviews
repaglinide 1 mg-metformin 500 mg tablet hypoglycemics - sulfonylureas and related non-sulfonylureasOn LabelRXReviews
rezvoglar kwikpen 100 unit/ml (3 ml) subcutaneous intermediate-, long-acting, and combination insulinsOn LabelRXReviews
semglee (insulin glargine-yfgn) 100 unit/ml subcutaneous solution intermediate-, long-acting, and combination insulinsOn LabelRXReviews
semglee (insulin glargine-yfgn) pen 100 unit/ml (3 ml) subcutaneous intermediate-, long-acting, and combination insulinsOn LabelRXReviews
semglee pen u-100 insulin 100 unit/ml (3 ml) subcutaneous intermediate-, long-acting, and combination insulinsOn LabelRXReviews
semglee u-100 insulin 100 unit/ml subcutaneous solution intermediate-, long-acting, and combination insulinsOn LabelRXReviews
trijardy xr 25 mg-5 mg-1,000 mg tablet, extended release antihyperglycemic, dipeptidyl peptidase-4 (dpp-4) inhibitorsOn LabelRXReviews
trulicity 3 mg/0.5 ml subcutaneous pen injector antihyperglycemic, incretin mimetic agentOn LabelRXReviews